Capella 6212 Assessment 2

Assessment 2: Executive Summary

Student Name

Capella University

School of Nursing and Health Sciences, Capella University

NURS-FPX 6212 Assessment 2:

Health Care Quality and Safety Management

Prof. Name:

Date

Executive Summary: Existing Outcome Measures Related to Medication Errors

Introduction: 

This executive summary addresses the existing outcome measures related to medication errors identified through an in-depth gap analysis. Medication errors represent a critical safety concern within our healthcare organization, necessitating immediate attention and strategic interventions. This summary provides an insightful perspective on the current state of medication error outcomes, emphasizing their strategic value and their role in fostering a culture of quality and safety.

Essential Quality and Safety Outcomes: 

Medication errors yield grave consequences for patient safety and healthcare outcomes. Crucial quality and safety outcomes tied to medication errors encompass adverse drug events (ADEs), patient harm, healthcare-associated infections, extended hospital stays, and escalated healthcare costs (Skelly et al., 2022; Fracica & Fracica, 2021; Säfholm et al., 2019; Walker et al., 2022). These outcomes starkly underscore the urgency of addressing medication errors and amplifying the quality of patient care.

Strategic Value of Outcome Measures: 

The existing outcome measures concerning medication errors hold profound strategic importance for our organization. Through scrutinizing ADE rates, medication error rates, and incidents of patient harm, we gain insight into the efficacy of current interventions and areas necessitating enhancement (Fracica & Fracica, 2021; Schutijser et al., 2019; Cardiff et al., 2020; Walker et al., 2022). Furthermore, these measures provide a window into the implications of medication errors on patient outcomes and financial matters, NURS FPX 6212 Assessment 2: Executive Summary, facilitating resource allocation and well-informed decision-making.

Relationship Between Systemic Problems and Outcomes: 

The systemic challenge posed by medication errors intricately intertwines with the identified outcomes. Elevated ADE and medication error rates spotlight deficiencies in medication administration processes, breakdowns in communication, and inadequate staff training. Addressing these systemic concerns directly correlates with mitigating adverse outcomes, substantiating a clear cause-and-effect linkage—Capella 6212 Assessment 2.

Supporting Quality and Safety Culture: 

Specific outcome measures linked to medication errors substantiate strategic endeavours aimed at cultivating a quality and safety culture within our organization. By meticulously monitoring and elevating ADE and medication error rates, we exemplify our dedication to patient safety and a trajectory of continual advancement. Enabling a culture that upholds transparent error reporting and fosters collaborative problem-solving stands to fortify medication safety even further.

Leadership Team Support for Implementation: 

The leadership team’s support remains pivotal in implementing proposed changes to tackle medication errors. Recognizing the strategic significance of these outcome measures, leadership can allocate resources to bolster staff education, integrate cutting-edge technologies, and usher in process enhancement initiatives. NURS FPX 6212 Assessment 2: Executive Summary. Moreover, their advocacy for transparent reporting and a blame-free environment resonates with staff, kindling a shared commitment to curbing medication errors.

Capella 6212 Assessment 2

Conclusion: 

The existing outcome measures affiliated with medication errors provide us with a comprehensive comprehension of our quality and safety challenges. By adroitly leveraging these measures, we can usher in targeted interventions to decrease medication errors and refine patient care outcomes. The leadership team’s unwavering support in steering these changes is paramount to germinating a safety culture and ceaseless quality enhancement within our organization. Addressing medication errors transcends enhancing patient safety—it is synonymous with elevating our organization’s reputation for delivering unparalleled, high-quality care.

References: 

Cardiff, S., Sanders, K., Webster, J., & Manley, K. (2020). Guiding lights for effective workplace cultures that are also good places to work. International Practice Development Journal, 10(2). https://doi.org/10.19043/ipdj.102.002v2

Fracica, P. J., & Fracica, E. A. (2021). Patient safety. In P. J. Fracica & E. A. Fracica (Eds.), Medical Quality Management: Theory and Practice (pp. 53-90). Springer.
Schutijser, B. C. F. M., Jongerden, I. P., Klopotowska, J. E., Portegijs, S., de Bruijne, M. C., & Wagner, C. (2019). Double checking injectable medication administration: Does the protocol fit clinical practice?. Safety Science, 118, 853-860. https://doi.org/10.1016/j.ssci.2019.06.026

Säfholm, S., Bondesson, Å., & Modig, S. (2019). Medication errors in primary health care records: A cross-sectional study in Southern Sweden. BMC Family Practice, 20, 1-7. https://doi.org/10.1186/s12875-019-1001-0

Skelly, C. L., Cassagnol, M., & Munakomi, S. (2022). Adverse events. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558963/

NURS FPX 6212 Assessment 2: Executive Summary

Walker, M., Hutchison, J., Lesak, D., Calvo, L., Friese, J., Garza, C., & Budin, L. (2022). Decreasing medication errors at discharge: A quality improvement project. Pediatrics, 149(1 Meeting Abstracts February 2022), 145-145. https://doi.org/10.1097/pq9.0000000000000599